Thibault DESMAREST

Bio

After studying medical biology at the Université Pierre et Marie Curie in Paris, Thibault Desmarest went on to study business at the EDHEC Group in Lille and then at Harvard Business School in Boston in 2013. He began his career in 1997 at Synthélabo France, before joining AstraZeneca France in 2000, where he held various sales positions of increasing responsibility. In 2006, he became Director of Sales Network Excellence at Sanofi's global headquarters in France, then moved to the United States as Director of Sales & Marketing Excellence for the US subsidiary, before taking on responsibilities for Strategy & Business Excellence at the Global Oncology Division. He left the US in 2012 to move to Japan. There, he initially held marketing responsibilities at national level, before being appointed General Manager for a geographical area including Japan, Australia, New Zealand and Korea. In 2016, he returned to France as Global Brand Leader, before being appointed Vice President in charge of the Northern Europe Region in 2020. These international experiences within a major French company have enabled him to promote French pharmaceutical excellence throughout the world. In February 2022, he was appointed President of GSK France, a leading international biopharmaceutical company in France. In this position for over two years, Thibault Desmarest is committed to raising the profile of the French subsidiary within GSK. Thanks to his commitment, at the last Choose France summit, GSK laboratory announced €600 million of investment between 2024 and 2026 in France, in R&D as well as for the three production sites. Thibault Desmarest has also been a board member of the Leem since 2022.